LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Edgewise Therapeutics (NASDAQ: EWTX)

Follow NASDAQ:EWTX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ EWTX Edgewise Therapeutics
Blaustein Robert / officer: Chief Development Officer
08/12/2025
Buy
$13.39
105,000
$1.406M
105,000
NASDAQ EWTX Edgewise Therapeutics
MOORE JOHN R / officer: General Counsel
08/12/2025
Buy
$13.39
161,250
$2.159M
161,250
NASDAQ EWTX Edgewise Therapeutics
MOORE JOHN R / officer: General Counsel
08/12/2025
Sell
$13.39
2,098
$28K
10,214
NASDAQ EWTX Edgewise Therapeutics
Derakhshan Behrad / officer: Chief Business Officer
08/12/2025
Buy
$13.39
180,000
$2.410M
180,000
NASDAQ EWTX Edgewise Therapeutics
Derakhshan Behrad / officer: Chief Business Officer
08/12/2025
Sell
$13.39
2,491
$33K
23,645
NASDAQ EWTX Edgewise Therapeutics
Carruthers R Michael / officer: Chief Financial Officer
08/12/2025
Buy
$13.39
161,250
$2.159M
161,250
NASDAQ EWTX Edgewise Therapeutics
Carruthers R Michael / officer: Chief Financial Officer
08/12/2025
Sell
$13.39
1,428
$19K
86,162
NASDAQ EWTX Edgewise Therapeutics
Russell Alan J / director, officer: Chief Scientific Officer
08/12/2025
Buy
$13.39
168,750
$2.260M
168,750
NASDAQ EWTX Edgewise Therapeutics
Russell Alan J / director, officer: Chief Scientific Officer
08/12/2025
Sell
$13.39
1,907
$26K
23,400
NASDAQ EWTX Edgewise Therapeutics
KOCH KEVIN / director, officer: President and CEO
08/12/2025
Buy
$13.39
525,000
$7.030M
525,000
NASDAQ EWTX Edgewise Therapeutics
KOCH KEVIN / director, officer: President and CEO
08/12/2025
Sell
$13.39
7,972
$107K
30,615
NASDAQ EWTX Edgewise Therapeutics
Donovan Joanne M. / officer: CMO
08/12/2025
Buy
$13.39
168,750
$2.260M
168,750
NASDAQ EWTX Edgewise Therapeutics
Donovan Joanne M. / officer: CMO
08/12/2025
Sell
$13.39
2,862
$38K
25,361

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous